LINASUG-M 2.5/500

Linagliptin 2.5 mg combined with Metformin Hydrochloride 500 mg is a potent oral antidiabetic medication formulated for adults with type 2 diabetes mellitus. This fixed-dose combination utilizes two complementary mechanisms:

• Linagliptin is a DPP-4 inhibitor that enhances incretin hormones, leading to increased insulin secretion and decreased glucagon release, both in a glucose-dependent manner.

• Metformin Hydrochloride is a biguanide that primarily reduces hepatic glucose production, improves insulin sensitivity, and enhances peripheral glucose uptake.

Together, they offer effective glycemic control by lowering fasting and postprandial blood glucose levels and reducing HbA1c. This combination is usually prescribed alongside diet and lifestyle modifications to optimize diabetes management.